NIKA PHARMACEUTICALS, INC. Shareholders' Equity
NIKA PHARMACEUTICALS, INC. (NIKA) had Shareholders' Equity of -$330.68 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent -$330.68K.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$310.99K; Stockholders' Equity Attributable to Parent as first filed -$310.99K.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$297.63K.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$260.54K.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$330.68K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | -$310.99K 10-Q · filed 2026-08-10 | -$310.99K 10-Q · filed 2026-05-12 |
| 2025-12-31 | -$297.63K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | -$260.54K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | -$252.56K 10-Q · filed 2026-08-10 | |
| 2025-03-31 | -$234.18K 10-Q · filed 2026-08-10 | |
| 2024-12-31 | -$221.23K 10-Q · filed 2026-08-10 | -$221.23K 10-K · filed 2025-03-31 |
| 2024-09-30 | -$200.41K 10-Q · filed 2025-11-07 | -$208.78K 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$208.78K 10-Q · filed 2025-11-07 | -$246.61K 10-Q · filed 2024-09-18 |
| 2024-03-31 | -$224.48K 10-Q · filed 2025-11-07 | |
| 2023-12-31 | -$82.15K 10-K · filed 2026-03-25 | -$17.32K 10-Q · filed 2023-08-21 |
| 2023-09-30 | -$74.83K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$64.69K 10-Q · filed 2024-11-12 | |
| 2023-03-31 | -$36.89K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | -$17.32K 10-K · filed 2025-03-31 | |
| 2022-09-30 | -$2.27K 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $4.07K 10-Q · filed 2023-10-31 | |
| 2022-03-31 | $83.00 10-Q · filed 2023-10-31 | |
| 2021-12-31 | -$23.62K 10-K · filed 2024-04-01 | |
| 2021-09-30 | -$20.32K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$17.62K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | -$14.66K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | -$8.91K 10-K · filed 2023-04-10 | |
| 2020-09-30 | -$160.00 10-Q · filed 2021-11-12 |